At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Oxytocin on Craving and Therapy Response in Marijuana-dependent Individuals
In Brief
A clinical study evaluating Oxytocin and Saline for Marijuana Dependence. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the impact of a medication called oxytocin on marijuana use and therapy response in people who frequently use marijuana.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMarijuana Dependence
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedApr 2013
Primary CompletionJun 2015
Study CompletionJul 2016
TodayJul 2026
First PostedApr 9, 2013
Enrollment StartMar 1, 2013
Primary CompletionJun 1, 2015
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.2 years ago
Interventions
Oxytocindrug
Subjects will be administered 40 IUs of oxytocin nasal spray or matching placebo prior to two individual sessions of MET.
Salinedrug
Subjects will be administered 40 IUs of oxytocin nasal spray or matching placebo prior to two individual sessions of MET.